Product News: Gael Teams up with CompliancePath to Reduce Validation Times to Within 25 days

Gael Ltd has partnered with leading Life Science validation specialists, CompliancePath, to offer a “fast track” validation service for customers.

CompliancePath brings together over 20 years’ experience in the Pharmaceutical, Biotechnology, Healthcare and Medical Device industries to deliver full service validation and compliance solutions at affordable prices.

Glasgow-based CompliancePath will boost Gael’s overall service to customers, providing a full end-to-end validation service of Q-Pulse, Gael’s flagship compliance management solution, for organisations in the UK, Europe, Middle East and Asia. The partnership between both companies will help reduce the full system validation time for organisations to within 25 days.

Hugh Devine, Managing Director at CompliancePath, said: "CompliancePath are delighted to announce our partnership with Gael which we believe represents a powerful opportunity to provide a validated accelerator pack to our regulated clients.

"The partnership is a strong strategic fit, leveraging both companies’ respective strengths which will benefit customers across three main areas. We are excited to be working with Gael and look forward to our continued joint success in the Life Science industry."

The three main areas CompliancePath and Gael will benefit customers include:

• Requirements for both 21 CFR Part 11 in the US and Annex 11 in the EU are met.
• Allow customers to be resource lean by reducing the time taken to execute key validation documents.
• Reduce the overall project cost for customers.

Since being launched in 2011, CompliancePath has gained a strong understanding of both the challenges companies face and the skills required to overcome them. They are already a leader in US and EU GxP, HIPAA, HITECH and NHS Directive solutions and their experienced project team members implement creative strategies to meet compliance needs, freeing customers to focus on their primary business objectives.

Gael’s flagship compliance management solution, Q-Pulse, provides an electronic centralised system for managing all compliance data, materials and activities. Q-Pulse can manage life science business functions efficiently and effectively in order to assure patients, the public and staff of the quality and safety of products and services within the Pharmaceutical, Medical Device and Biotech industries.

Chris Evans, Commercial Strategist for Gael’s Life Science team, said: "We are delighted to welcome CompliancePath as a collaborative partner. Computer software validation is a daunting, yet mandatory, activity within the Pharmaceutical and Medical Device industries and CompliancePath’s industry expertise provides risk based, cost effective validation services. Q-Pulse is the cornerstone of compliance practices for our regulated customers and through this partnership, Gael and CompliancePath, will be able to deliver a truly end-to-end compliance solution."